Medrysone
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a606003 |
Pregnancy category |
|
Routes of administration | Eye drops |
ATC code | S01BA08 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 2668-66-8 |
PubChem (CID) | 247839 |
IUPHAR/BPS | 7086 |
DrugBank | DB00253 |
ChemSpider | 216968 |
UNII | D2UFC189XF |
KEGG | D02289 |
ChEMBL | CHEMBL1201173 |
Chemical and physical data | |
Formula | C22H32O3 |
Molar mass | 344.488 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Medrysone (INN, USAN), also known as 6α-Methyl-11β-hydroxyprogesterone or 11β-hydroxy-6α-methylpregn-4-ene-3,20-dione, is a corticosteroid that has been used in optometry, and in ophthalmology for the treatment of eye inflammations.[1][2] It has been discontinued in the US.[2]
References
This article is issued from Wikipedia - version of the 10/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.